NCT06556563 · Interventional trial
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Overall registry status Active not recruiting
Phase 3
Conditions Glioblastoma
Delaware Valley sites
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Clinical Trials Organization · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory